Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Vogelmeier

Showing results (71-80 of 158) with videos related to

Pageof 16
Sort By:
Respiratory Medicine|October 30, 2012
Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patientsClaus Vogelmeier, Leonardo M Fabbri, Klaus F Rabe, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 14, 2009
Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbationsKai-Michael Beeh, Bettina Hederer, Thomas Glaab, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 24, 2016
Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysisClaus Vogelmeier, Nanshan Zhong, Michael J Humphries, et al.
Pulmonary Pharmacology & Therapeutics|February 9, 2018
Compatibility of medication with PRISCUS criteria and identification of drug interactions in a large cohort of patients with COPDJana Graf, Tanja Lucke, Ronald Herrera, et al.
The European Respiratory Journal|May 7, 2013
FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohortsAlvar Agusti, Suzanne Hurd, Paul Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Allergic airway inflammation inhibits pulmonary antibacterial host defenseChristoph Beisswenger, Kerstin Kandler, Christian Hess, et al.
Pneumologie (Stuttgart, Germany)|June 19, 2026
Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendationsMichael Dreher, Markus Fischer, Chrisian Karagiannidis, et al.
COPD|May 5, 2015
Sex differences in alpha-1-antitrypsin deficiency lung disease-analysis from the German registrySebastian Fähndrich, Christian Herr, Timm Greulich, et al.
Orphanet Journal of Rare Diseases|June 11, 2016
Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015Timm Greulich, Christoph Nell, Christian Herr, et al.
Sleep|September 21, 2005
Nonrandom variability of respiration during sleep in healthy humansSven Rostig, Jan W Kantelhardt, Thomas Penzel, et al.
Pageof 16

Showing results (71-80 of 158) with videos related to

Sort By:
Pageof 16
Respiratory Medicine|October 30, 2012
Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patientsClaus Vogelmeier, Leonardo M Fabbri, Klaus F Rabe, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 14, 2009
Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbationsKai-Michael Beeh, Bettina Hederer, Thomas Glaab, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 24, 2016
Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysisClaus Vogelmeier, Nanshan Zhong, Michael J Humphries, et al.
Pulmonary Pharmacology & Therapeutics|February 9, 2018
Compatibility of medication with PRISCUS criteria and identification of drug interactions in a large cohort of patients with COPDJana Graf, Tanja Lucke, Ronald Herrera, et al.
The European Respiratory Journal|May 7, 2013
FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohortsAlvar Agusti, Suzanne Hurd, Paul Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Allergic airway inflammation inhibits pulmonary antibacterial host defenseChristoph Beisswenger, Kerstin Kandler, Christian Hess, et al.
Pneumologie (Stuttgart, Germany)|June 19, 2026
Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendationsMichael Dreher, Markus Fischer, Chrisian Karagiannidis, et al.
COPD|May 5, 2015
Sex differences in alpha-1-antitrypsin deficiency lung disease-analysis from the German registrySebastian Fähndrich, Christian Herr, Timm Greulich, et al.
Orphanet Journal of Rare Diseases|June 11, 2016
Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015Timm Greulich, Christoph Nell, Christian Herr, et al.
Sleep|September 21, 2005
Nonrandom variability of respiration during sleep in healthy humansSven Rostig, Jan W Kantelhardt, Thomas Penzel, et al.
Pageof 16